- LEARNING CENTERS
- JOIN GRU
- Your GRU
- Log In
San Diego, California
October 16-18, 2020
Founded in January 2017, the International Bladder Cancer Update (IBCU) is a one-day CME conference to discuss diagnosis and treatment of about bladder cancer. The conference offers medical professionals an opportunity to listen to updates from and interact with expert, international faculty to improve knowledge and determine best treatment practices to improve patient outcomes. IBCU is held during its sister conference, the International Prostate Cancer Update (IPCU).
IBCU encompasses expert lectures, interactive discussions, a panel roundtable, debates, and case presentations. It is physician-led, multi-supported, and designed for urologists, urologic oncologists, and other healthcare professionals involved in the treatment of bladder cancer.
The goal of this educational program is to equip healthcare professionals involved in the treatment of bladder cancer with up-to-date clinical knowledge and tools they need to best treat their patients. The program will compare and contrast the treatment of bladder cancer that is both muscle invasive (MIBC) and non-muscle invasive (NMIBC). From diagnosis and staging guidelines to treatment options in clinical trials, the program will give physicians a comprehensive review of the most up-to-date best practices in bladder cancer treatment.
CME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Carden Jennings Publishing. The Medical College of Wisconsin is accredited with commendation by the ACCME to provide continuing medical education for physicians.
View faculty interviews from the 3rd Annual International Bladder Cancer Update
Michael Cookson, MD, MMHC
Professor and Chairman of the Department of Urology
University of Oklahoma College of Medicine
Daniel Petrylak, MD
Director of the Genitourinary Oncology Section
Yale Cancer Center
New Haven, CT